Home › Stocks › LCTX › All Fund Holders
LCTX — LINEAGE CELL THERAPEUTICS IN · All Fund Holders
Funds holding (latest): 33 · Reported value held: $58.32M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 13.19M | $17.27M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 9.64M | $16.11M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 5.30M | $6.94M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 3.02M | $3.95M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.66M | $2.17M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 1.47M | $1.93M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 1.34M | $1.76M | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 1.28M | $1.68M | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 687.05K | $900.04K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 577.43K | $756.44K | 0.00% | Add |
| Wellington Management Group history | Q1 2024 | 467.55K | $691.97K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 465.57K | $609.90K | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 433.27K | $567.58K | 0.00% | Reduce |
| Bank of America Corp history | Q2 2026 | 424.37K | $555.93K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 391.68K | $513.09K | 0.00% | Add |
| Point72 Asset Management history | Q1 2026 | 304.36K | $480.89K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 192.93K | $252.73K | 0.00% | Hold |
| Deutsche Bank AG history | Q2 2026 | 183.32K | $240.15K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 183.12K | $239.88K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 100.13K | $131.17K | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 86.53K | $116.81K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 86.60K | $113.45K | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2023 | 56.36K | $84.54K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 54.95K | $71.98K | 0.00% | Reduce |
| Manulife Financial history | Q3 2024 | 57.95K | $52.47K | 0.00% | Hold |
| Prudential Financial history | Q2 2026 | 29.80K | $39.03K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 17.99K | $23.56K | 0.00% | New |
| D. E. Shaw & Co history | Q3 2024 | 25.58K | $23.16K | 0.00% | Reduce |
| AQR Capital Management history | Q3 2025 | 11.65K | $19.69K | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 14.10K | $18.48K | 0.00% | New |
| PNC Financial Services history | Q4 2025 | 252 | $421 | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 151.23K | $199 | 0.00% | New |
| Lazard Asset Management history | Q4 2024 | 148 | $0 | — | Hold |